Tue 1 Dec 2009 | 23:15 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Impax Laboratories, Inc.

Impax Laboratories, Inc. (IPXL.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View IPXL on other exchanges
As of  1 Dec 2009
11.57USD
Price Change
+0.17
Percent Change
+1.49%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 30 Dec 2008
Benet, Leslie -- -- -- --
Burr, Robert -- -- -- --
Fleming, Nigel -- -- -- --
Hildenbrand, Charles 551,862 -- 184,447 736,309
Hsu, Larry 1,331,860 -- 378,234 1,710,090
Koch, Arthur 671,909 -- 247,429 919,338
Markbreiter, Michael -- -- -- --
Mengler, Christopher -- -- -- --
Nestor, Michael 302,404 -- 386,249 725,972
Oh, Kim Sun -- -- -- --
Terreri, Peter -- -- -- --